Today, Vanda Pharmaceuticals Inc (NASDAQ: VNDA) Takes Center Stage

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Vanda Pharmaceuticals Inc is $268.25M. A total of 0.86 million shares were traded on the day, compared to an average of 622.75K shares.

In the most recent transaction, Polymeropoulos Mihael Hristos bought 10,000 shares of VNDA for 5.01 per share on Mar 06 ’25. After the transaction, the President and CEO now owns 2,295,731 company shares. In a previous transaction on Mar 05 ’25, Polymeropoulos Mihael Hristos bought 10,000 shares at 5.02 per share. VNDA shares that President and CEO owns now total 2,285,731.

Among the insiders who bought shares, Polymeropoulos Mihael Hristos acquired of 10,000 shares on Mar 03 ’25 at a per-share price of $4.71. This resulted in the President and CEO holding 2,275,731 shares of VNDA after the transaction. In another insider transaction, Polymeropoulos Mihael Hristos bought 10,000 shares at $4.76 per share on Feb 28 ’25. Company shares held by the President and CEO now total 2,361,730.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, VNDA has a high of $6.75 and a low of $3.86.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. VNDA’s latest balance sheet shows that the firm has $432.81M in Cash & Short Term Investments as of fiscal 2021. There were $12.37M in debt and $74.42M in liabilities at the time. Its Book Value Per Share was $9.24, while its Total Shareholder’s Equity was $504.93M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VNDA is Buy with a score of 4.33.

Most Popular

Related Posts